Ipilimumab/nivolumabColitis: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1735卷 / 1期

关键词：

D O I：

10.1007/s40278-019-56776-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：160 / 160

相关论文

共 50 条

[21] Ipilimumab/NivolumabColitis
Reactions Weekly, 2024, 2005 (1) : 464 - 464
[22] Ipilimumab/nivolumabColitis and skin toxicity: case report
Reactions Weekly, 2018, 1696 (1) : 213 - 213
[23] NivolumabColitis and liver toxicity: 2 case reports
Reactions Weekly, 2020, 1818 (1) : 212 - 212
[24] Ipilimumab/nivolumabColitis and bilateral mydriasis: case report
Reactions Weekly, 2022, 1907 (1) : 266 - 266
[25] Interferon-alpha/ipilimumab/nivolumabColitis, granulomatous lymphadenitis and psychosis: 3 case reports
Reactions Weekly, 2023, 1939 (1) : 254 - 254
[26] Ipilimumab/nivolumabColitis and lack of efficacy: case report
Reactions Weekly, 2022, 1903 (1) : 214 - 214
[27] NivolumabColitis: 6 case reports
Reactions Weekly, 2019, 1754 (1) : 258 - 258
[28] NivolumabColitis: 3 case reports
Reactions Weekly, 2018, 1723 (1) : 228 - 228
[29] Ipilimumab/nivolumabColitis and off label use : case report
Reactions Weekly, 2024, 2018 (1) : 252 - 252
[30] Binimetinib/encorafenib/ipilimumab/nivolumabColitis and diarrhoea: case report
Reactions Weekly, 2023, 1959 (1) : 147 - 147

← 1 2 3 4 5 →